Duodenal-jejunal bypass liner therapy (Endobarrier®) causes reductions in plasma trimethylamine-N-oxide in obese patients with diabetes

A Ruban, M Glaysher, H Ashrafian, A Miras, C Prechtl, A Goldstone, M Aldhwayan, N Chhina, W Al-Najim, J Li, J Byrne, J Teare

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Original languageEnglish
Title of host publicationGUT
PublisherBMJ Publishing Group
EditionIssue Suppl 1
Publication statusPublished online - 21 Jan 2021

Cite this